Device Trial Radar · NCT02146352
AXIOS Stent With Electrocautery Enhanced Delivery System
Last checked: Nov 20, 2026Latest source record: Oct 2, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Sponsor
- Lead sponsor
- Xlumena, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- May 23, 2014
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to demonstrate the safety and effectiveness of the AXIOS Stent with Electrocautery Enhanced Delivery System for endoscopic transenteric drainage of pancreatic pseudocysts.
Conditions
- Pancreatic Pseudocyst(s)
Interventions
AXIOS Stent with Electrocautery Enhanced Delivery SystemDevice
Endoscopy with ultrasonography to implant AXIOS stent using electrocautery enhanced delivery system to allow drainage of pancreatic pseudocyst. Removal of AXIOS stent after 30 or 60 days.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety/Adverse Event Outcome Measure 1Time frame: Index procedure through 1-week post-stent removal
5 more outcomes with a free account
Locations
8 sites in 1 country. Site status is shown where the registry gives one.
University of Colorado Denver
Aurora, Colorado
7 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.